ClinicalTrials.gg
RecruitingNCT07105943Updated May 4, 2026

Manipulating Exercise Intensity and Affective Responses for Cardiac Rehabilitation Program Acute Coronary Syndrome Patients

An interventional study of Control and Experimental in Affect and Exertion During and Post-exercise, sponsored by Instituto Politécnico de Leiria. Recruiting at 2 sites in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by Instituto Politécnico de Leiria · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Acute Coronary Syndrome with a site in Portugal — 1 open to participants now, 1 under way, none of them phase 3. Acute Coronary Syndrome · Portugal.

Planned enrollment
14th of 15
52 · median 6,068
Started
2026
the only one that year
No phase
2 of 18
1 open now
Registered
18th of 18
by date
Lead sponsor
1 of 18
Instituto Politécnico de Leiria

Among the 18 studies in Acute Coronary Syndrome with a site in Portugal, this one is the 14th largest by planned enrollment of the 15 interventional ones that give a count, is the only one that started in 2026, is one of 2 with no phase, and was the 18th registered.

Acute Coronary Syndrome

1,491 studies on the registry are indexed under Acute Coronary Syndrome; 272 are open to participants now.

Browse Acute Coronary Syndrome studies →

Open to participants now

1 of the 18 studies in Acute Coronary Syndrome with a site in Portugal is open now.

A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →

Who these studies take

Of the 195 Acute Coronary Syndrome studies recruiting now, 144 (74%) set no upper age limit and 19 (10%) stop at 75 or younger; 15 take children under 18; 15 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Acute Coronary Syndrome with a site in Portugal, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if pleasure-oriented exercise intensity manipulation increases physical activity (PA) behavior in patients who have suffered acute coronary syndrome during a cardiac rehabilitation program. The main question it aims to answer is:

  • the manipulation of exercise intensity performed to produce more pleasure and arousal will impact the PA behavior? Researchers will compare the PA levels and affective responses to see if the manipulation of exercise intensity guided to pleasure and arousal works to increase PA behavior compared to the control group who will follow a conventional exercise program.

Participants will do:

  • sixteen individualized hospital exercise sessions (two per week) and complementary physical activity program integrated into their daily life
  • be evaluated before and at the end of the exercise sessions and after 3 months
Read the detailed description

Ischaemic heart disease remains the top global cause of death, with cases rising by 2.7 million to 9.0 million deaths over the past two decades and between 1990-2019 the percentage of years of life lived with disability increased 83%.

Ischaemic heart disease includes acute coronary syndromes (ACS) that consist of acute myocardial infarction (AMI) and unstable angina. After ACS there is a greater risk of recurrence of the event, arrhythmias, heart failure and sudden death. These patients also have a lower quality of life which impacts their physical function and psychological well-being. ACS represent a substantial direct cost and economic burden for national health systems. Prevention must be prioritized and the emphasis on encouraging physical activity (PA) and routine exercise has become more vital than ever.

The 2023 European Society of Cardiology Guidelines for the management of ACS recommend that all patients participate in a medically supervised, structured, comprehensive cardiac rehabilitation (CR) program with a multidisciplinary team. Its core components are patient assessment, management and control of cardiovascular risk factors, PA counselling, prescription of exercise training, dietary advice, tobacco counselling, patient education, psychosocial management, and vocational support. Exercise plays a key role having a Class I, Level A evidence supporting its benefits, while specific components such as aerobic PA and muscle-strengthening exercises are supported by Class I, Level B evidence. CR plays a crucial role in lowering rates of hospitalization, fatal and non-fatal myocardial infartion, while improving exercise capacity and quality of life. There is also a reduction in healthcare costs for participants in a CR program compared with nonparticipants.

CR typically consists of three phases: phase 1 (in-hospital), phase 2 (mostly in an outpatient setting: centre-based or home-based) and phase 3 (maintenance phase in outpatient or community settings, aimed at sustaining lifestyle changes). Phase 2 CR is typically provided as an outpatient program, lasting between 8 to 24 weeks, with sessions offered 3 to 7 days per week.

A progressive program of structured exercise and PA are a fundamental part of a CR program. Exercise training should be tailored to the individual, following a thorough clinical assessment that includes risk stratification, behavioral traits, personal objectives, and exercise preferences. Exercise should be prescribed based on FITT-VP (frequency, intensity, time, type of exercise, volume, and progression) model. It is recommended to do aerobic training at a frequency of at least 3 days per week, with a preference for 6-7 days per week, at a moderate or moderate-to-high intensity. It is also advised to do resistance training, 2 days per week, at 30-70% of one-repetition maximum (1RM) for the upper body and 40-80% of 1RM for the lower body, with 12-15 repetitions/set. After the end of the CR program (i.e., beginning of phase 3), ACS patients should accumulate at least 30 minutes per day, 5 days per week of moderate intensity PA (equating to 150 minutes per week) or 15 minutes per day, 5 days per week of vigorous intensity PA (equating to 75 minutes per week), or a combination of both. These PA levels are needed for reducing disease progression and increasing quality of life.

Despite being aware of the benefits of regular PA and intending to stay active, many patients struggle to adopt or maintain these behaviors in the long-term. One-third of their sample did not reach the recommended PA levels in the first weeks after discharge from CR. Moreover, in long-term approximately 66% of patients failed to meet the established PA goal.

The central problem is the sustainability of PA after phase 2 CR. Therefore, strategies aimed at improving patients' attitudes toward and adherence to exercise are warranted.

Patient should be actively participating in their exercise program, tailoring it to their needs and preferences, as personalized care increases the likelihood of improved adherence to an exercise routine during and after CR. Knowing that adherence is influenced by complex psychological factors, exploring them should be a crucial effort in such programs. As such, exploring the individual motivation may be a relevant consideration for such effort.

Patient should be actively participating in their exercise program, tailoring it to their needs and preferences, as personalized care increases the likelihood of improved adherence to an exercise routine during and after CR. Knowing that adherence is influenced by complex psychological factors, exploring them should be a crucial effort in such programs. As such, exploring the individual motivation may be a relevant consideration for such effort.

Improving adherence to phase 3 CR recommendations The success of a CR program could be measured by the extent of the individual recovery process and the ability to introduce sustainable, long-lasting behavioral changes capable of preventing relapse, where PA is a crucial component. In apparently healthy individuals, several theories and approaches have been used for adherence support and healthy habits adoption. These are often grounded in motivational aspects, where several prominent theories have been used.

In the CR context, some efforts have been made for this purpose. Some studies used Self-Determination Theory assumptions to explore its potential role in supporting PA in these patients. Results indicated that promoting basic psychological needs satisfaction and supporting autonomy predicted PA/exercise behavior. In other studies, the Theory of Planned Behavior was used as the theoretical background for the same exploration, and once again, evidence was found to the theory underpinnings, mainly for intention, and their positive relation to PA. These are just a few examples of how the study of motivation has been used in the past in CR programmes to try to improve patient adherence in later phases and to support lifestyle changes. However, these are also examples that mimic several of the current issues in translating motivational and behavioral theories into practice, not only in these programmes, but also for general PA promotion. For once, these suggestions emerge from cross-sectional and longitudinal studies, thus evidencing the struggle that translating and operationalization the distinct theories' assumptions brings, given the absence in the last decades of experimental efforts in the most of contexts. Then, it is also possible to easily verify that CR programmes still struggle to improve PA adherence in later stages of the recovery process, even though the unquestionable, evidence-based indication of its worthiness, and the ever-growing support emerging from psychological theories of motivation.

Given that this is not an exclusive problem in this context and patients, researchers concerned with the motivational aspects of PA have been exploring other possibilities and approaches. One that will be used to support the current study's experimental approach is grounded on the emerging line of the psychological study of affectivism. This line of thought assumes that non-rational aspects of behavior, as is the case with core affect, can influence individual motivational development through a hedonistic lens (i.e., tendency to approach activities that promote pleasurable sensations, and to avoid those experienced as unpleasant ones). Core affect is posited to be a neurophysiological state that is consciously accessible as a simple, nonreflective feeling that is an integral blend of hedonic (pleasure-displeasure) and arousal (sleepy-activated) values. Some recent efforts grounded on dual-process theories, where core affect is an integral component of implicit and, indirectly, reflective pathways, have been made in similar CR programmes. That showed support for the role of affective attitudes in supporting PA, thus evidencing the emerging concern and focus of potential affective constructs in this matter.

Current study In PA settings, several conditions can manifest in these feelings (i.e., core affect) and thus impact motivation, but one stands as the one more directly responsible - exercise intensity. As posited by the Affect and Health Behavior Framework (AHBF) and the Dual Mode Theory (DMT), intensity is closely related to core affect manifestations. Generally, the exposure to higher intensities is tendentially experienced as unpleasant, and lower intensities as pleasant. Often, a pleasurable heterogeneity zone emerges between some metabolic (e,g., ventilatory threshold) or load (\~75% RM) thresholds that anticipate the decrease and often emergence of unpleasant responses . A successful and individual experience of pleasurable responses is posited to support motivation development and subsequently align with being physically active and supporting lifestyle changes, but experimental efforts to test these theoretical assumptions are lacking.

There is a study where it was manipulated the exercise intensity to promote pleasurable experiences in individualized exercise sessions in fitness centers. An 8-week follow-up showed that the experimental group had a 77% higher session attendance when compared to the control group (14.35 vs. 8.13). This was achieved using the ACSM exercise guidelines for healthy adults, were the exercise intensity, in the experimental group, was adjusted to support pleasurable affective responses and align with individual intensity preference and tolerance, in an autonomy supportive manner.

The current study will be developed in an ongoing CR program aligned with the European Association of Preventive Cardiology (EAPC) guidelines, which presents its own specification of the FITT-VP principles. As such, the general conditions to allow the manipulation of exercise intensity and the replication of the motivational approach are present and are inherently of relevance for increasing phase 2 and 3 CR physical activity levels.

03

Conditions studied

  • Affect and Exertion During and Post-exercise

Keywords

  • acute coronary syndrome
  • cardiac rehabilitation
  • physical activity
  • affective response
  • motivation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Selection criteria include:

  • patients older than 18 years
  • diagnosis of ACS within the past 12 months who have not previously participated in a CR program
  • patients classified as low-risk (Class B) according to the American Heart Association: (a) (NYHA) class I or II, (b) exercise capacity greater than 6 METs, (c) no evidence of heart failure, (d) no signs of myocardial ischemia or angina at rest or during exercise testing at or below 6 METs, (e) appropriate systolic blood pressure response during exercise, and (f) absence of sustained or non-sustained ventricular tachycardia at rest or during exercise.

Standard exclusion criteria include:

  • (LVEF) \< 40% at rest
  • uncontrolled arrythmias (e.g., complex ventricular arrhythmias, atrial fibrillation or flutter with rapid ventricular response, second-degree atrioventricular block Mobitz type II, or third-degree atrioventricular block)
  • presence of an implantable cardiac device
  • symptomatic peripheral arterial disease
  • comorbidities that may interfere with the ability to perform the exercise program safely.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
52 participants (estimated)

Study arms

  • Active comparator
    Control

    Other: Control

  • Experimental
    Experimental

    Other: Experimental

Interventions

  • OtherControl

    The intervention will be implemented in the 8 weeks phase 2 cardiac rehabilitation program. Both groups will receive a pre-exercise evaluation and 16 individualized training sessions (two per week) based on FITT-VP principles and according to the European Association of Preventive Cardiology (EAPC) guidelines. A complementary physical activity program integrated into their daily life will be prescribed. It will receive regular briefing sessions regarding the health-related benefits of exercise. After these sessions, it will be recommended to maintain physical activity aiming to reach at least 150 min/week of moderate intensity PA.

  • OtherExperimental

    As for the experimental group, in the 16 individualized training sessions (two per week), attention will be given to exercise intensity assessment and manipulation, with the goal of optimizing the affective experience of exercise, while also respecting minimum and maximum intensity thresholds as proposed by the EAPC (self-selected intensity within individually defined limits). The pre-exercise evaluation, the number of sessions, and methodological approach will be the same to the control group. In this group it will be presented some awareness of the potential of choosing fun and pleasant activities.

06

What researchers measure

Primary outcomes

  1. Physical activity levels by International Physical Activity Questionnaire - Short Form

    International Physical Activity Questionnaire - Short Form: physical activity will be assessed by a continuous variable, expressed in MET-minutes per week. It will be applied in order to evaluate the same week of accelerometry.

    Time frame: At baseline (the week before phase 2 cardiac rehabilitation program), end of the intervention (first week after the intervention) and at 3 months after it

  2. Affective responses in exercise sessions phase 2 cardiac rehabilitation program - Felt Arousal Scale

    Felt Arousal Scale is a 6-point scale ranging from 1 ("Low arousal") to 6 ("High arousal") that assesses perceived activation

    Time frame: During all exercise sessions (twice a week for 8 weeks) will be administered at 10-min intervals during the aerobic activity; immediately after the fourth and eighth resistance exercises set and in the last 15 sec of the set of the fifth stretch exercise

  3. Physical activity levels by accelerometry

    We will use the ActiGraph® GT3X+ (Pensacola, FL) accelerometer. The researcher will distribute the accelerometers to all participants, that will be instructed to wear the device on an elastic belt around their waist on the right side for seven consecutive days, taking it off only for water-based activities (e.g., shower and swimming) and sleep. Participants will be asked to carry out their usual activities during data collection. The cut points and wear time validation criteria will be used to define the time spent in each intensity period and to define a valid register. A day will be considered valid with at least 600 minutes of use, and each participant will have to present at least four valid days, including a at least one weekend day to be included in the analysis. Compliance with PA recommendations for public health will be assessed according to EAPC recommendations (150 min/week of MVPA defined as ≥ 21.4 min/day).

    Time frame: At baseline (the week before phase 2 cardiac rehabilitation program), end of the intervention (first week after the intervention) and at 3 months after it

  4. Affective responses in exercise sessions phase 2 cardiac rehabilitation program - Feeling Scale

    Feeling Scale is an 11-point scale ranging from -5 ("Very bad") to +5 ("Very good"), which assesses the affective valence (how one feels at that given moment)

    Time frame: During all exercise sessions (twice a week for 8 weeks) will be administered at 10-min intervals during the aerobic activity; immediately after the fourth and eighth resistance exercises set and in the last 15 sec of the set of the fifth stretch exercise

Secondary outcomes

  1. Participation in the complementary physical activity program

    minutes-week of physical activity

    Time frame: In the 8 weeks of the intervention

  2. Anticipated affective response

    Anticipated affective response to a future exercise session measured with the adaptation of the Empirical Valence Scale will be used to assess anticipated affective response to exercise sessions. This instrument uses 15 empirically spaced verbal anchors ranging from -100 ("Most unpleasant imaginable") to +100 ("Most pleasant imaginable"). Participants will respond to the question "Considering the workout you are about to begin (previously explained/remembered), how do you think it will make you feel?".

    Time frame: 5 minutes before the exercise sessions 1, 8 and 16 during the intervention (exercise sessions are twice a week for 8 weeks)

  3. Final remembered affect to the previous exercise session

    Remembered affect of previous exercise session measured with the Visual Analog Scale A Visual Analog Scale (VAS) will be used to assess remembered exercise pleasure/displeasure. Participants will be asked to rate "How did your last workout make you feel?". This scales ranges from +100 ("very pleasant") to -100 ("very unpleasant").

    Time frame: 5 minutes after exercise sessions 1, 8 and 16 during intervention (exercise sessions are twice a week for 8 weeks)

  4. Intention to continue exercising

    The behavioral intention will be assessed using three items (e.g., "I will continue to practice physical exercise in the next 6 months as I recently practiced \[with or without personal trainer\] or in a very similar way (same type, frequency, duration, and intensity"). Responses are entered using a 7-point ordinal scale ranging from 1 ("Absolutely not") to 7 ("Absolutely yes").

    Time frame: 5 min before session 1 and 5 min after session 16 during intervention (exercise sessions are twice a week for 8 weeks). At the end of the intervention (first week after the intervention) and at 3 months after it

  5. Exercise habit

    The Self-Report Behavioral Automaticity Index will be used to assess behavioral habit development. The instrument consists of four items (e.g., "I do without thinking") answered on a 7-point Likert scale, ranging from 1 ("Totally disagree") to 7 ("Totally agree").

    Time frame: 5 min before session 1 and 5 min after session 16 during intervention (exercise sessions are twice a week for 8 weeks). At the end of the intervention (first week after the intervention) and at 3 months after it

  6. Exercise enjoyment

    Exercise enjoyment measured with the the Physical Activity Enjoyment Scale (PACES). This questionnaire includes eighteen items related to "how do you felt during the exercise you have recently completed?" that are answered using a 7-point bipolar scale with antithetical statements (e.g., item 1: "I loved it - I hated it").

    Time frame: 5 minutes before session 1 and 5 minutes after sessions 8 and 16 during intervention (exercise sessions are twice a week for 8 weeks).

  7. Intensity preference, tolerance, and agreement of exercise

    The Preference for and Tolerance of Exercise Intensity Questionnaire (PRETIE-Q) will be used to assess individual differences in intensity-preference, intensity-tolerance, and the agreement between self-reported preference and tolerance with the intensity experienced during the preceding exercise session. The instrument is composed of 10 items (five for each factor; preference: "Low-intensity exercise is boring"; tolerance: "Feeling tired during exercise is my signal to slow down or stop") answered on a 5-point Likert scale ranging from 1 ("Totally disagree") to 5 ("Totally agree"). The two additional questions proposed by this instrument version to assess agreement will also be used as recommended.

    Time frame: 5 minutes before session 1 and 5 minutes after session 8 and 16 during intervention (exercise sessions are twice a week for 8 weeks).

  8. Motivation to exercise

    Intrinsic motivation from the the Intrinsic Motivation Inventory will be used. Minor adaptations to the wording will be made to ensure relevance to the context of exercise (e.g., vs. sport) following the example of adaptations in similar studies . For example, "I am satisfied with my performance at this task" (perceived competence) will be adapted to "I am satisfied with my performance in these workouts".

    Time frame: 5 minutes before session 1 and 5 minutes after session 8 and 16 during intervention (exercise sessions are twice a week for 8 weeks).

  9. Autonomy in exercise practice

    Autonomy in exercise practice measured with the perceived choice scale of the Intrinsic Motivation Inventory. Minor adaptations to the wording will be made to ensure relevance to the context of exercise (e.g., vs. sport) following the example of adaptations in similar studies . For example, "I believe I had some choice about doing this activity" (perceived choice) will be adapted to "I believe I had some choice during these workouts". One item will be added to the perceived choice subscale regarding the freedom to select exercise intensity, i.e., "I felt I had the choice to switch the intensity of exercise as I wished".

    Time frame: 5 minutes before session 1 and 5 minutes after session 8 and 16 during intervention (exercise sessions are twice a week for 8 weeks).

  10. Abdominal Circumference

    The measurement will be taken with the patient standing, naked on the upper part, the measuring tape is placed at the midpoint between the costal margin and the upper edge of the iliac crest, at the end of expiration, with the measuring tape straight and without tightening

    Time frame: Baseline, at the end of the intervention (first week after the intervention) and at 3 months after it

  11. Body mass index (BMI)

    BMI (weight (kg) / \[height (m)\]²).

    Time frame: Baseline, at the end of the intervention (first week after the intervention) and at 3 months after it

  12. Body weight

    Body weight (kg) will be measured using an electronic balance.

    Time frame: Baseline, at the end of the intervention (first week after the intervention) and at 3 months after it

  13. Height

    Height (m) will be obtained from identification cards

    Time frame: Baseline

Other outcomes

  1. Resting blood pressure

    Resting blood pressure (mmHg) - systolic and diastolic. It will be tested on the right upper limb of the seated patient.

    Time frame: Before and after all exercise sessions during the intervention (exercise sessions are twice a week for 8 weeks).

  2. Heart rate during exercise

    Heart rate will be monitored using a telemetry system

    Time frame: During all the exercise sessions during the intervention (exercise sessions are twice a week for 8 weeks).

  3. Perceptions of effort

    Perceptions of effort assessed by Borg Rating of Perceived Exertion Scale 15-point (Borg Scale)

    Time frame: During all exercise sessions the Borg Scale will be administered at 10-min intervals during the aerobic activity; immediately after the set of the fourth and eighth resistance exercises, and in the last 15 sec of the fifth stretch exercise

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Dec 2027, 21 months after the start.

Of 213 non-industry interventional studies with no phase under Acute Coronary Syndrome, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 46. This study's planned 21 months is below that.

Counting every sponsor, half of 228 studies reached it within 34 months; a quarter within 17 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 17, 2025
First posted
Aug 6, 2025
StartActual
Mar 1, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Mar 31, 2028
Last update
May 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07105943
Lead sponsor
Instituto Politécnico de Leiria
Collaborators
Universidade Lusófona de Humanidades e Tecnologias, Centro Hospitalar de Leiria, Rede de Investigação em Saúde
Responsible party
Filipa Januario (Collaborator Member, Instituto Politécnico de Leiria) — Principal investigator
First posted
Aug 6, 2025
Start date
Mar 1, 2026
Primary completion
Dec 31, 2027 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
May 4, 2026

Study contacts

Filipa Januario, MMed
Contact
filipa.januario@ulsrl.min-saude.pt
+351817073

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion